JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (BKK:JSP)
Thailand · Delayed Price · Currency is THB 1.780
-0.020 (-1.11%)
Aug 11, 2026, 11:18 AM ICT
BKK:JSP Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,020 | 1,043 | 845.93 | 594.36 | 466.8 | 429.13 |
Revenue Growth | 11.04% | 23.26% | 42.33% | 27.32% | 8.78% | -7.27% |
Gross Profit Gross Profit Growth | 427.72 | 438.01 | 326.44 | 162.3 | 153.69 | 151.15 |
Operating Income Operating Income Growth | 107.24 | 109.68 | 102.35 | -0.41 | -1.07 | 48.3 |
Net Income Net Income Growth | 60.83 | 67.87 | 4.52 | -1.72 | -17.48 | 29.69 |
Earnings Per Share EPS Growth | 0.13 | 0.14 | 0.01 | -0.00 | -0.04 | 0.08 |
EPS Growth | 312.13% | 1368.43% | - | - | - | -13.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Manufacture and Sell of Products under Customers' Brand Name (OEM) Manufacture and Sell of Products under Customers' Brand Name (OEM) Growth | 347.51 | 352.96 | 308.39 | 288.49 | 249.38 | 274.2 |
Manufacture and Sell of Products under The Company's Brand Name (Own Brand) Manufacture and Sell of Products under The Company's Brand Name (Own Brand) Growth | 395.75 | 419.62 | 337.2 | 192.74 | 168.91 | 139.95 |
Manufacture and Sell of Hemodialysis Products, Equipment and Supplies Manufacture and Sell of Hemodialysis Products, Equipment and Supplies Growth | 191.98 | 184.74 | 140.03 | 64.67 | - | - |
Service, Product Research, and Healthcare Products Training Service, Product Research, and Healthcare Products Training Growth | 14.6 | 15.8 | 8.04 | 7.74 | 29.19 | - |
Other Segments Other Segments Growth | 33.95 | 37.1 | 30.84 | 21.95 | 10.6 | 8.19 |
Unallocated Revenues Unallocated Revenues Growth | 36.04 | 32.46 | 21.45 | 18.78 | 8.73 | 6.79 |
Total Total Growth | 1,020 | 1,043 | 845.93 | 594.36 | 466.81 | 429.13 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 46.44 | 48.03 | 29.49 | 20.65 | 310.01 | 650.9 |
Total Debt Total Debt Growth | 401.97 | 381.17 | 288.41 | 290.53 | 189.12 | 183.45 |
Net Cash (Debt) Net Cash Growth | -355.53 | -333.14 | -258.92 | -269.88 | 120.89 | 467.46 |
Net Cash Growth | - | - | - | - | -74.14% | - |
Net Cash Per Share Net Cash Per Share Growth | -0.76 | -0.70 | -0.55 | -0.58 | 0.25 | 1.30 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 89.13 | 130.93 | 132.12 | 40.35 | 2.81 | 51.72 |
Capital Expenditures CapEx Growth | -278.71 | -279.27 | -56.42 | -172.89 | -288.7 | -36.55 |
Free Cash Flow Free Cash Flow Growth | -189.58 | -148.33 | 75.69 | -132.55 | -285.89 | 15.17 |
Free Cash Flow Growth | - | - | - | - | - | -60.93% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.94% | 42.01% | 38.59% | 27.31% | 32.92% | 35.22% |
Operating Margin | 10.51% | 10.52% | 12.10% | -0.07% | -0.23% | 11.25% |
Pretax Margin | 9.20% | 9.59% | -3.94% | 0.92% | -3.38% | 8.72% |
Profit Margin | 5.96% | 6.51% | 0.53% | -0.29% | -3.74% | 6.92% |
FCF Margin | -18.59% | -14.23% | 8.95% | -22.30% | -61.25% | 3.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.095 | 0.100 | 0.032 | - | - | 0.013 |
Dividend Per Share Growth | 0% | 216.46% | - | - | - | - |
Dividend Yield | 5.27% | 5.40% | 1.65% | - | - | 0.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.27 | 13.29 | 211.87 | - | - | 113.40 |
P/FCF Ratio | - | - | 12.67 | - | - | 221.88 |
PS Ratio | 0.84 | 0.87 | 1.13 | 1.84 | 3.53 | 7.85 |